Artificial intelligence (AI) is transforming how we solve problems, make decisions, and address some of the world’s most complex challenges. Advancing AI responsibly requires more than technology alone.
A cure for the previously incurable. That’s the big promise of Advanced Therapy Medicinal Products (ATMPs), and it’s attracting big numbers. In 2020 alone, the global ATMP industry raised $19.9B in annual financing, a 200% increase over 2019.
Green bonds have proven to be an effective way to mobilize capital becuase they have the same fundamental risk and return characteristics as conventional bonds
Apynov is a French company based in Toulouse that specializes in smart home technology, including voice-activated connected devices under its “Konyks” partner brand. Its distribution network includes SFR (a leading French telecom), Orange (Europe’s third-largest telecom) and retailers like Boulanger, Leclerc, Intermarché and Monsieur Bricolage. The company is also part of the French tech initiative, which supports startup ecosystems in cities across the country.
The sustainable mini-boats are a more affordable, effective and sustainable alternative to existing methods of trash retrieval, such as hand and fishing net retrieval methods. In addition, they send back actionable environmental data about waste collected.
Goodyear and SARTA, two Northeast Ohio-based leaders in future mobility, today announced a collaboration to test intelligent tire sensors and prototype tires on SARTA’s fleet of diesel and zero emission hydrogen fuel cell-powered buses.
Programs like Innovation for Good program are effective ways to harness associate passion to innovate and challenge them to explore creative products and solutions for pressing global issues including safe sanitation, hygiene and safe water.
Rockwell Automation’s (NYSE: ROK) Jason Heineberg’s 3D printing expertise and hobby gives new meaning to the phrase “lend a hand.” Based in Cape Town, South Africa, the information software technical consultant produces 3D-printed prosthetic hands that are provided free to patients who otherwise could not afford them.
Embracing the notion of a hybrid partner will support Europe-based life science innovators in delivering drug therapies faster and more cost-effectively.
The business landscape is reorienting itself and you can almost hear priorities shifting toward change-readiness and the bigger picture. And in this...
